ATE401862T1 - Stabile oxaliplatin zubereitungen - Google Patents

Stabile oxaliplatin zubereitungen

Info

Publication number
ATE401862T1
ATE401862T1 AT06254598T AT06254598T ATE401862T1 AT E401862 T1 ATE401862 T1 AT E401862T1 AT 06254598 T AT06254598 T AT 06254598T AT 06254598 T AT06254598 T AT 06254598T AT E401862 T1 ATE401862 T1 AT E401862T1
Authority
AT
Austria
Prior art keywords
solution
oxaliplatin
carbohydrate
amount
pharmaceutical composition
Prior art date
Application number
AT06254598T
Other languages
English (en)
Inventor
Satish Chandra Upadhyay
Manoj Kumar Pananchukunnath
Ajeet Kumar Singh
Deepti Jain
Deepak Judgelal Parshotamdas
Rama Mukharjee
Anand C Burman
Original Assignee
Dabur Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Pharma Ltd filed Critical Dabur Pharma Ltd
Application granted granted Critical
Publication of ATE401862T1 publication Critical patent/ATE401862T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06254598T 2005-09-05 2006-09-04 Stabile oxaliplatin zubereitungen ATE401862T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN809KO2005 2005-09-05

Publications (1)

Publication Number Publication Date
ATE401862T1 true ATE401862T1 (de) 2008-08-15

Family

ID=37745604

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06254598T ATE401862T1 (de) 2005-09-05 2006-09-04 Stabile oxaliplatin zubereitungen

Country Status (7)

Country Link
US (1) US7674824B2 (de)
EP (1) EP1776947B1 (de)
AT (1) ATE401862T1 (de)
DE (1) DE602006001917D1 (de)
ES (1) ES2311268T3 (de)
PT (1) PT1776947E (de)
WO (1) WO2007029268A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007061763A1 (de) 2007-12-20 2009-06-25 Bayer Healthcare Ag Substituierte azabicyclische Verbindungen und ihre Verwendung
JP5963156B1 (ja) * 2016-03-23 2016-08-03 テバ製薬株式会社 オキサリプラチンを含む水性医薬組成物の製造方法及び安定化方法
US11975047B1 (en) 2022-10-28 2024-05-07 Ani Pharmaceuticals, Inc. Methods for storing and warming purified corticotropin compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
JP3547755B2 (ja) 1994-08-08 2004-07-28 デビオファーム・エス・アー オキサリプラティヌムの医薬的に安定な製剤
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
US6378714B1 (en) * 1998-04-20 2002-04-30 Becton Dickinson And Company Transferset for vials and other medical containers
CA2382389C (fr) * 1999-08-30 2010-06-29 Debiopharm S.A. Preparation pharmaceutique stable d'oxaliplatine pour administration par voie parenterale
EP1404689A1 (de) * 2001-07-02 2004-04-07 Debiopharm S.A. Aktive oxiplatinverbindung mit sehr niedrigem oxalsaüregehalt
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
DE10314377A1 (de) 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
CN102048723A (zh) 2003-08-28 2011-05-11 梅恩医药有限公司 含有酸的奥沙利铂制剂

Also Published As

Publication number Publication date
US7674824B2 (en) 2010-03-09
DE602006001917D1 (de) 2008-09-04
WO2007029268A2 (en) 2007-03-15
EP1776947B1 (de) 2008-07-23
ES2311268T3 (es) 2009-02-01
PT1776947E (pt) 2008-10-31
WO2007029268B1 (en) 2007-07-12
WO2007029268A3 (en) 2007-05-31
US20070054957A1 (en) 2007-03-08
EP1776947A1 (de) 2007-04-25

Similar Documents

Publication Publication Date Title
DE60309731D1 (de) Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern
PE20081477A1 (es) Formulacion liofilizada mab abeta
UA97234C2 (ru) Раствор хлорида натрия для восстановления влагосодержания композиции лиофилизированного фактора ix
EA200800160A1 (ru) Композиты восстановленной ионной жидкостью целлюлозы в качестве матриц твёрдых подложек
EA200870480A1 (ru) Новые композиции, стабилизирующие иммуногенные композиции и ингибирующие их осаждение
WO2007109260A3 (en) Silicone elastomer gels
BRPI0410679A (pt) fórmulas de proteìna lìquida estabilizada em conteiners farmacêuticos cobertos
BR0309894A (pt) Composição, processo para preparar uma composição de celulose microcristalina, produto alimentìcio, composição farmacêutica, composição cosmética, forma de dosagem farmacêutica, e, composição industrial
BR9914932A (pt) Processo para a manufatura de uma composição de isotretinoìna, composição de isotretinoìna micronizada, forma de dosagem unitária para administração enteral e composição farmacêutica na forma de dosagem unitária
CL2012001310A1 (es) Composicion que comprende un oligopeptido ciclo-(arg-gly-asp-dphe-nmeval) que tiene una solubilidad en agua a 20ºc de entre 1 mg/ml y 20 mg/ml y con uno o varios compuestos lipofilicos y/o anfifílicos; proceso para preparar dicha composicion.
CA2784827C (en) Composition of dexibuprofen transdermal hydrogel
WO2010079487A3 (en) Compositions for decontamination
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
BRPI0413957A (pt) processo para preparar diterpenos solúveis em água, solução aquosa e suas aplicações
DK0506866T3 (da) Fremgangsmåde til krystallisation af enzymer
WO2007005633A3 (en) Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
DE602006001917D1 (de) Stabile Oxaliplatin Zubereitungen
TW200505764A (en) Glass substrate package
YU28102A (sh) Vodena farmaceutska kompozicija koja sadrži ciklesonid
WO2003068247A1 (en) Eye installation based on iodine anions
BRPI0509482A (pt) complexo compreendendo piroxicam, uma ciclodextrina e a arginina, processo de preparação de um complexo, composição farmacêutica, processo de preparação de um composto de inclusão solúvel, e composto de inclusão solúvel
CA2534259A1 (en) Glycyrrhizin high-concentration preparation
RU2010136488A (ru) Способ стабилизации антител в водных растворах
ZA200805598B (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
CL2009000960A1 (es) Dispersion acuosa de particulas que contienen fructano, donde el d50 de las particulas de 2-50um y un 61%-80% p/p de materia solida; proceso de elboracion que comprende mezclar fructano y agua, opcionalmente hidrolizar hasta 5-25% p/p de fructanos no solubles, opcionalmente purificar, concentrar hasta un 61-80% p/p de materia solida.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties